To halt brain diseases, drugs take aim at protein traffic jams that kill neurons
Elie Dolgin • January 16, 2019
Compound that normalizes flow of proteins in cells will now be tested in a clinical trial for ALS
Continue reading at Science Magazine.
AI and real-time neural feedback could transform treatments.
Pixels meet paint, as a digital “mask” conceals damage on a 15th-century painting.